Rovas, Alexandros
Buscher, Konrad
Osiaevi, Irina
Drost, Carolin Christina
Sackarnd, Jan
Tepasse, Phil-Robin
Fobker, Manfred
Kühn, Joachim
Braune, Stephan
Göbel, Ulrich
Thölking, Gerold
Gröschel, Andreas
Rossaint, Jan
Vink, Hans
Lukasz, Alexander
Pavenstädt, Hermann
Kümpers, Philipp http://orcid.org/0000-0001-9929-0703
Funding for this research was provided by:
Innovative Medical Research Fund of the University of Münster Medical School (I-RO221907)
Innovative Medical Research Fund of the University of Münster Medical School (I-RO221907)
Deutsche Forschungsgemeinschaft (ZA428/18-1, ZA428/18-1, KU 2873/3-1, RO 4537/5-1, LU-2321/1-1)
Westfälische Wilhelms-Universität Münster
Article History
Received: 27 February 2022
Accepted: 23 May 2022
First Online: 20 June 2022
Declarations
:
: AR, KB, IO, CD, JS, PRT, MF, JK, SB, UG, GT, AG, JR, AL, HP, PK declare no competing interests. HV is Chief Science Officer of GlycoCheck BV, The Netherlands.
: The study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the General Medical Council Westfalen-Lippe and the WWU Münster, Germany (File Number: amendments of 2016-073-f-S).
: Patients were enrolled upon after obtaining written informed consent from them or their legal representatives.